| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99241 |
|
537 |
394 |
$53K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
252 |
246 |
$30K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
339 |
284 |
$23K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
498 |
365 |
$21K |
| 99242 |
|
39 |
39 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
277 |
198 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
152 |
112 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
87 |
70 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
334 |
259 |
$595.54 |
| S9083 |
Global fee urgent care centers |
32 |
30 |
$200.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
51 |
51 |
$143.72 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
170 |
123 |
$78.50 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
67 |
55 |
$62.60 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$45.80 |
| 81003 |
|
16 |
13 |
$4.36 |